Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity.
The expression of several markers of epithelial cell proliferation was analyzed to establish baseline data for future chemoprevention studies of oral premalignant lesions. Punch biopsies (n = 60) from three different sites of oral mucosa (bucca, lateral tongue, and the floor of the mouth) were obtained from 20 normal donors of both sexes. After formaldehyde fixation and paraffin embedding, immunohistochemistry was used to detect the proliferation markers Mib-1, cyclin D1, and centromere-associated protein CENP-F. Analysis of sections stained for the three markers showed similar patterns, i.e., a low labeling index (LI) in the basal layer and a high LI in the parabasal layer at all three intraoral sites. No proliferative activity was seen above the parabasal layer (superficial layer). All sites showed similar Mib-1 LI values for the proliferative markers. The tongue epithelium exhibited higher parabasal LIs of cyclin D1 and CENP-F than did the other two sites. No significant differences were detected between smokers and nonsmokers. The data from normal mucosa were compared with those from low (n = 30)- and high (n = 17)-grade dysplastic leukoplakias. The Mib-1 LI showed a very significant change, with a 9-fold increase in the basal layer LI in dysplastic leukoplakias. Cyclin D1 and CENP-F showed similar trends with increments of up to 7-fold in the basal layer of high-grade dysplasia. Although the proliferative activity of the parabasal layer was similar in normal and leukoplakic epithelia, the superficial layer showed a significant increment in proliferative activity mainly in high-grade leukoplakia. These studies suggest that proliferation markers in the basal and superficial cells of premalignant lesions may serve as surrogate end point biomarkers for chemoprevention trials.
Liu
S C
SC
Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Sauter
E R
ER
Clapper
M L
ML
Feldman
R S
RS
Levin
L
L
Chen
S Y
SY
Yen
T J
TJ
Ross
E
E
Engstrom
P F
PF
Klein-Szanto
A J
AJ
D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor / Q000032:analysis*; D002278:Carcinoma in Situ / Q000737:chemistry* / Q000473:pathology; D002455:Cell Division; D002868:Chromosomal Proteins, Non-Histone / Q000032:analysis*; D019938:Cyclin D1 / Q000032:analysis*; D004847:Epithelial Cells / Q000737:chemistry* / Q000166:cytology / Q000473:pathology; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen; D007972:Leukoplakia, Oral / Q000737:chemistry* / Q000473:pathology; D008297:Male; D008840:Microfilament Proteins; D009061:Mouth Mucosa / Q000737:chemistry* / Q000166:cytology / Q000473:pathology; D009687:Nuclear Proteins / Q000032:analysis*
D034961:Antigens, Nuclear; D014408:Biomarkers, Tumor; D002868:Chromosomal Proteins, Non-Histone; D019394:Ki-67 Antigen; D008840:Microfilament Proteins; D009687:Nuclear Proteins; C094772:centromere protein F; D019938:Cyclin D1